Instrument NameOrganigram Hlds IncInstrument Symbol(OGI-Q)

Instrument ExchangeNASDAQ

These three buy-rated cannabis stocks could be set to benefit as both leading presidential candidates show growing support for legalization.

OGI earnings call for the period ending June 30, 2024.

The investment is meant to help Organigram capitalize on the recent legalization of cannabis in Germany, where Sanity is based and holds a roughly 10% share of the medical marijuana market

OGI earnings call for the period ending March 31, 2024.

While they do carry higher-than-average risk, these microcaps also offer major upside potential for investors seeking startup-sized returns.

OGI earnings call for the period ending December 31, 2023.

OGI earnings call for the period ending September 30, 2023.

Organigram says the investment will help it extend its footprint beyond Canada and strengthen its financial position for long-term, sustainable growth

There's some potentially very good news coming soon from the halls of Congress.

Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential, according to analysts.

OGI earnings call for the period ending June 30, 2023.

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023 (“Q2 Fiscal 2023”). All financial information in this...

Tilray is buying Hexo at a big discount to Monday's closing share price.

Consolidation is going to be the key theme among Canadian cannabis companies in 2023 and beyond.

Two catalysts are propelling the pot company's shares higher today.

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it has entered into a product purchase agreement (“Purchase Agreement”) with Green Tank Technologies Corp....

With fears of economic turbulence receding, Aurora Cannabis, Canopy Growth, and Organigram rebounded from their Monday declines.

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that BAT has designated Ms. Caroline Ferland as a nominee to Organigram’s board of directors (the “Board”). Caroline Ferland is a lawyer with extensive...

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package...

Focus on the long-term possibilities with companies that are already financially strong.

Organigram Holdings Inc. (“ Organigram ” or the “ Corporation ”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders held on February 28, 2023 (the “ Meeting ”).

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED X Rip-Strip Hash, a first-of-its-kind innovation in the Canadian cannabis...

Cannabis companies aren’t required to pass along the savings to consumers by lowering their prices, so many observers believe licensed producers will adopt a range of pricing strategies